Francesca Barone - 03 Feb 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Scientific Officer
Signature
/s/ John Canepa, as Attorney-In-Fact for Francesca Barone
Issuer symbol
CADL
Transactions as of
03 Feb 2022
Net transactions value
$0
Form type
4
Filing time
07 Feb 2022, 16:40:15 UTC
Next filing
01 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 03 Feb 2022 Common Stock 40,000 $4.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments over four years following the Grant Date, subject to the Reporting Person's continued service on each such vesting date.